Metsa Group makes second investment in start-up FineCell that produces pulp-based materials for beauty, healthcare, paint products; FineCell technology turns pulp into added-value biomaterial that can be used as powder and as water solution, ie hydrogel

Sample article from our R&D/Patents

December 14, 2023 (press release) –

The FineCell technology can turn pulp into added-value biomaterial that can be used both as a powder and as a water solution, i.e., a hydrogel. These can replace fossil-based chemicals in beauty and healthcare products, as well as in paints. FineCell is a spinout of the KTH Royal Institute of Technology in Stockholm, Sweden.

The CellOx material is made through the novel and innovative FineCell technology, which combines cellulose with a natural chemical - oxalic acid found in e.g. rhubarb - producing a new material that is completely biobased, light to ship, and compared to other similar cellulose products, requires 80–90% less energy to manufacture. CellOx can easily carry other ingredients, making it an excellent binding agent for products such as sunscreens, skin creams, and paints. It’s also transparent, enabling it to be used in a large variety of products. 

“The world is scrambling to replace fossil-based materials with sustainable ones. Our product, based on softwood pulp from Nordic forests, gives many industries an alternative to the components they are currently using,” says Peter Axegård, CEO and co-owner of FineCell. “Metsä Spring has seen the potential in our innovation, and due to their know-how in planning, constructing and operating production plants, including pilots and demos, and their access to the raw material linked to their ambition to upgrade Nordic wood, they were the perfect choice to support us as we move forward.”

Globally, the race to replace fossil-based ingredients in everyday products is central to many sectors. The chemical complexity of these products means that replacing ingredients requires a clear sustainability impact without compromising performance. 

“We’ve been following FineCell for some time and are delighted to now be part of their journey. For us, all technologies that convert softwood pulp into added-value products are of interest. This technology and product clearly stand out, making it especially interesting. The FineCell technology is still young. At this stage, we do not yet know all the directions that this technology platform might take us,” says Niklas von Weymarn, CEO of Metsä Spring.

FineCell aims to have the design of its demo plant ready for investment decision by the end of 2024. The company plans to have larger-scale test production underway during 2025, with full commercial production commencing in 2027.

Media kit with pictures

For further information please contact:

Niklas von Weymarn, CEO, Metsä Spring Oy, tel. +358 40 547 6977

Peter Axegård, CEO, FineCell

Metsä Group

Metsä Group is leading the way in advancing the bioeconomy. We invest in growth, bioproduct development and a fossil free future. The raw material for our products is renewable wood from sustainably managed northern forests. We focus on the growth sectors of the forest industry: wood supply and forest services, wood products, pulp, fresh fibre paperboards, as well as tissue and greaseproof papers.

Metsä Group’s annual sales amount to approximately EUR 7 billion, and we have around 9,500 employees in around 30 countries. We promote a culture of diversity, equality and inclusion. Our international Group has its roots in the Finnish forests: our parent company is Metsäliitto Cooperative which is owned by over 90,000 forest owners. 

Follow Metsä Group: X  LinkedIn  Facebook  YouTube  Instagram  

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order r&d/patents coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.